Bart L. Haagmans

58.1k total citations · 12 hit papers
245 papers, 24.6k citations indexed

About

Bart L. Haagmans is a scholar working on Infectious Diseases, Epidemiology and Animal Science and Zoology. According to data from OpenAlex, Bart L. Haagmans has authored 245 papers receiving a total of 24.6k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Infectious Diseases, 92 papers in Epidemiology and 79 papers in Animal Science and Zoology. Recurrent topics in Bart L. Haagmans's work include SARS-CoV-2 and COVID-19 Research (123 papers), Animal Virus Infections Studies (79 papers) and Viral gastroenteritis research and epidemiology (50 papers). Bart L. Haagmans is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (123 papers), Animal Virus Infections Studies (79 papers) and Viral gastroenteritis research and epidemiology (50 papers). Bart L. Haagmans collaborates with scholars based in Netherlands, Germany and United States. Bart L. Haagmans's co-authors include Albert D. M. E. Osterhaus, V. Stalin Raj, Mart M. Lamers, Christian Drosten, Berend‐Jan Bosch, Saskia L. Smits, Marion Koopmans, Alexander E. Gorbalenya, Chris Lauber and Ron A. M. Fouchier and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Bart L. Haagmans

241 papers receiving 24.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

2020 5.0k citations Alexander E. Gorbalenya, Bart L. Haagmans et al. profile →
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

2013 1.5k citations V. Stalin Raj, Saskia L. Smits et al. profile →
Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients

2020 983 citations Nisreen M.A. Okba, Wentao Li et al. profile →
A human monoclonal antibody blocking SARS-CoV-2 infection

2020 729 citations Chunyan Wang, Wentao Li et al. Nature Communications profile →
Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans

2012 705 citations Sander van Boheemen, Miranda de Graaf et al. mBio profile →
Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome

2020 587 citations Daniela Weiskopf, Katharina S. Schmitz et al. Science Immunology profile →
SARS-CoV-2 pathogenesis

2022 555 citations Mart M. Lamers, Bart L. Haagmans profile →
Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

2013 503 citations Bart L. Haagmans, Chantal Reusken et al. profile →
Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells

2013 404 citations V. Stalin Raj, Bart L. Haagmans et al. profile →
Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein

2017 252 citations Wentao Li, Ivy Widjaja et al. profile →
Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

2022 147 citations Mart M. Lamers, Theo M. Bestebroer et al. profile →
ICTV Virus Taxonomy Profile: Coronaviridae 2023

2023 81 citations Bart L. Haagmans, Isabel Sola et al. profile →

Peers

Countries citing papers authored by Bart L. Haagmans

Since Specialization

Citations

This map shows the geographic impact of Bart L. Haagmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart L. Haagmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart L. Haagmans more than expected).

Fields of papers citing papers by Bart L. Haagmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart L. Haagmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart L. Haagmans. The network helps show where Bart L. Haagmans may publish in the future.

Co-authorship network of co-authors of Bart L. Haagmans

This figure shows the co-authorship network connecting the top 25 collaborators of Bart L. Haagmans. A scholar is included among the top collaborators of Bart L. Haagmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart L. Haagmans. Bart L. Haagmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SARS-CoV-2 ORF8 accessory protein is a virulence factor 2023 ·mBio ·Melissa Belló-Pérez, (unknown), Anna Z. Mykytyn, Mart M. Lamers, (unknown), Debby Schipper, (unknown), (unknown), (unknown), Pedro J. Sánchez‐Cordón, Luis Enjuanes, Bart L. Haagmans, Isabel Sola	6
2	Reduced Seasonal Coronavirus Antibody Responses in Children Following COVID-19 Mitigation Measures, The Netherlands 2023 ·Viruses ·Reina S. Sikkema, Erwin de Bruin, Christian Ramakers, Robbert G. Bentvelsen, Wentao Li, Berend‐Jan Bosch, Brenda M. Westerhuis, Bart L. Haagmans, Marion Koopmans, Pieter L. A. Fraaij	4
3	Glycosylated extracellular mucin domains protect against SARS-CoV-2 infection at the respiratory surface 2023 ·PLoS Pathogens ·Maitrayee Chatterjee, (unknown), Anna Z. Mykytyn, Chunyan Wang, Mart M. Lamers, Bart Westendorp, Richard Wubbolts, Jos P. M. van Putten, Berend‐Jan Bosch, Bart L. Haagmans, Karin Strijbis	19
4	Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters 2022 ·Emerging Microbes & Infections ·Melanie Rissmann, Danny Noack, Debby van Riel, Katharina S. Schmitz, Rory D. de Vries, Peter van Run, Mart M. Lamers, Corine H. GeurtsvanKessel, Marion Koopmans, Ron A. M. Fouchier, Thijs Kuiken, Bart L. Haagmans, Barry Rockx	7
5	Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns 2022 ·PLoS Pathogens ·Ilhan Tomris, Kim M. Bouwman, Youri Adolfs, Danny Noack, Roosmarijn van der Woude, Gius Kerster, Sander Herfst, Rogier W. Sanders, Marit J. van Gils, Geert‐Jan Boons, Bart L. Haagmans, R. Jeroen Pasterkamp, Barry Rockx, Robert P. de Vries	14
6	Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins 2021 ·PLoS Pathogens ·Kim M. Bouwman, Ilhan Tomris, Hannah L. Turner, Roosmarijn van der Woude, (unknown), Gerlof P. Bosman, Barry Rockx, Sander Herfst, Joost Snijder, Bart L. Haagmans, Andrew B. Ward, Geert‐Jan Boons, Robert P. de Vries	23
7	High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019 2021 ·The Journal of Infectious Diseases ·Werner J. D. Ouwendijk, Matthijs P. Raadsen, Jeroen J. A. van Kampen, Robert M. Verdijk, Jan H. von der Thüsen, Lihui Guo, Rogier A.S. Hoek, Johannes P. C. van den Akker, Henrik Endeman, Thomas Langerak, Richard Molenkamp, Diederik Gommers, Marion Koopmans, Eric C. M. Van Gorp, Georges M. G. M. Verjans, Bart L. Haagmans	49
8	A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies 2021 ·Nature Communications ·Chunyan Wang, Rien van Haperen, Francisco J. Gutierrez-Alvarez, Wentao Li, Nisreen M.A. Okba, Irina C. Albulescu, Ivy Widjaja, Brenda van Dieren, Raúl Fernández‐Delgado, Isabel Sola, Daniel L. Hurdiss, Olalekan Daramola, Frank Grosveld, Frank J. M. van Kuppeveld, Bart L. Haagmans, Luis Enjuanes, Dubravka Drabek, Berend‐Jan Bosch	95
9	Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets 2021 ·Science ·Rory D. de Vries, Katharina S. Schmitz, Francesca T. Bovier, (unknown), Jonathan Khao, Danny Noack, Bart L. Haagmans, Sander Herfst, (unknown), (unknown), (unknown), Barry Rockx, Gaël McGill, N. Valerio Dorrello, Samuel H. Gellman, Christopher A. Alabi, Rik L. de Swart, Anne Moscona, Matteo Porotto	157
10	Potent neutralizing antibodies for severe COVID-19: A randomized clinical trial 2021 ·Carlijn Jordans, Arvind Gharbharan, (unknown), (unknown), Barry Rockx, Bart L. Haagmans, Francis Swaneveld, Yolanda Mueller, Peter D. Katsikis, Matty Koopmans, Bart Rijnders, Casper Rokx	1
11	Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome breakdown → 2020 ·Science Immunology ·Daniela Weiskopf, Katharina S. Schmitz, Matthijs P. Raadsen, Alba Grifoni, Nisreen M.A. Okba, Henrik Endeman, Johannes P. C. van den Akker, Richard Molenkamp, Marion Koopmans, Eric C. M. Van Gorp, Bart L. Haagmans, Rik L. de Swart, Alessandro Sette, Rory D. de Vries	587
12	SARS-CoV-2 is transmitted via contact and via the air between ferrets 2020 ·Nature Communications ·Mathilde Richard, Adinda Kok, Dennis de Meulder, Theo M. Bestebroer, Mart M. Lamers, Nisreen M.A. Okba, Martje Fentener van Vlissingen, Barry Rockx, Bart L. Haagmans, Marion Koopmans, Ron A. M. Fouchier, Sander Herfst	314
13	An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment 2020 ·Nature Communications ·Corine H. GeurtsvanKessel, Nisreen M.A. Okba, Zsὁfia Iglὁi, Susanne Bogers, Carmen W.E. Embregts, Brigitta M. Laksono, Lonneke Leijten, Casper Rokx, Bart Rijnders, Janette Rahamat–Langendoen, Johannes P. C. van den Akker, Jeroen J. A. van Kampen, Annemiek A. van der Eijk, Rob van Binnendijk, Bart L. Haagmans, Marion Koopmans	231
14	DPP4, the MERS coronavirus receptor, is upregulated in lungs of smokers and COPD patients 2018 ·Lirias (KU Leuven) ·Leen Seys, W. Widagdo, Anne Verhamme, Alex KleinJan, Wim Janssens, Guy Joos, Ken R. Bracke, Bart L. Haagmans, Guy Brusselle	0
15	Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection 2018 ·Science Advances ·V. Stalin Raj, Nisreen M.A. Okba, Francisco J. Gutierrez-Alvarez, Dubravka Drabek, Brenda van Dieren, W. Widagdo, Mart M. Lamers, Ivy Widjaja, Raúl Fernández‐Delgado, Isabel Sola, Albert Bensaïd, Marion Koopmans, Joaquím Segalés, Albert D. M. E. Osterhaus, Berend‐Jan Bosch, Luis Enjuanes, Bart L. Haagmans	59
16	Genotypic anomaly in Ebola virus strains circulating in Magazine Wharf area, Freetown, Sierra Leone, 2015 2015 ·Eurosurveillance ·Saskia L. Smits, Suzan D. Pas, Chantal Reusken, Bart L. Haagmans, (unknown), Corrado Cancedda, Kerry Dierberg, (unknown), (unknown), David Kargbo, Sarah Caddy, Armando Arias, Lucy Thorne, Jia Lu, (unknown), Ian Goodfellow, Marion Koopmans	6
17	[Dromedary camels and Middle East respiratory syndrome: MERS coronavirus in the 'ship of the desert']. 2014 ·PubMed ·Chantal Reusken, Bart L. Haagmans, Marion Koopmans	9
18	Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans breakdown → 2012 ·mBio ·Sander van Boheemen, Miranda de Graaf, Chris Lauber, Theo M. Bestebroer, V. Stalin Raj, (unknown), Albert D. M. E. Osterhaus, Bart L. Haagmans, Alexander E. Gorbalenya, Eric J. Snijder, Ron A. M. Fouchier	705
19	Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms 2011 ·PLoS ONE ·Martin Lagging, Galia Askarieh, Francesco Negro, Stéphanie Bibert, Jonas Söderholm, Johan Westin, Magnus Lindh, Ana I. Romero, Gabriele Missale, Carlo Ferrari, Avidan U. Neumann, Jean–Michel Pawlotsky, Bart L. Haagmans, Stefan Zeuzem, Pierre–Yves Bochud, Kristoffer Hellstrand, (unknown)	122
20	Ip-10 Is Associated With Il28b Variation And Predicts The First Phase Decline Of Hcv Rna And Outcome Of Therapy In Chronic Hepatitis C 2010 ·IRIS ·Martin Lagging, Galia Askarieh, Pierre–Yves Bochud, Stéphanie Bibert, F. Negro, Gabriele Missale, Carlo Ferrari, Avidan U. Neumann, Jean–Michel Pawlotsky, Bart L. Haagmans, S W Schalm, Stefan Zeuzem, Jonas Söderholm, Johan Westin, Magnus Lindh, Kristoffer Hellstrand	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact